WMSA
REGN icon

Weiss Multi-Strategy Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,193
Closed -$5.44M – 383
2023
Q4 		$5.44M Buy
6,193
+5,614
+970% +$4.62M 0.13% 207
2023
Q3 		$476K Buy
+579
New +$455K 0.01% 486
2022
Q4 		– Sell
-4,095
Closed -$2.82M – 710
2022
Q3 		$2.82M Buy
4,095
+3,744
+1,067% +$2.36M 0.07% 336
2022
Q2 		$207K Sell
351
-1,832
-84% -$1.19M 0.01% 611
2022
Q1 		$1.52M Sell
2,183
-822
-27% -$520K 0.04% 439
2021
Q4 		$1.9M Sell
3,005
-1,506
-33% -$926K 0.04% 393
2021
Q3 		$2.73M Sell
4,511
-563
-11% -$350K 0.06% 361
2021
Q2 		$2.83M Sell
5,074
-795
-14% -$403K 0.06% 360
2021
Q1 		$2.78M Buy
5,869
+993
+20% +$483K 0.06% 360
2020
Q4 		$2.36M Buy
4,876
+1,876
+63% +$1.01M 0.05% 393
2020
Q3 		$1.68M Sell
3,000
-5,617
-65% -$3.41M 0.04% 371
2020
Q2 		$5.37M Buy
8,617
+7,117
+474% +$4.04M 0.15% 202
2020
Q1 		$732K Buy
+1,500
New +$619K 0.03% 324
2019
Q4 		– Sell
-2,000
Closed -$555K – 709
2019
Q3 		$555K Buy
+2,000
New +$592K 0.01% 483
2019
Q2 		– Sell
-2,500
Closed -$1.03M – 614
2019
Q1 		$1.03M Buy
+2,500
New +$1.03M 0.03% 389
2017
Q1 		– Sell
-2,024
Closed -$743K – 613
2016
Q4 		$743K Buy
+2,024
New +$770K 0.04% 299
2014
Q2 		– Sell
-2,980
Closed -$895K – 892
2014
Q1 		$895K Buy
2,980
+1,550
+108% +$478K 0.02% 512
2013
Q4 		$394K Buy
+1,430
New +$411K 0.01% 695

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Weiss Multi-Strategy Advisers's REGN Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Regeneron Pharmaceuticals (REGN) in Q1 2024, closing a stake of 6,193 shares — an estimated $5.44M sold.

Weiss Multi-Strategy Advisers first reported a position in REGN in Q4 2013 and held it in 18 quarters. The position peaked at $5.44M in Q4 2023. 1,309 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Regeneron Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 6,193 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $5.44M.
  • Weiss Multi-Strategy Advisers first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 18 quarters.
  • Weiss Multi-Strategy Advisers's Regeneron Pharmaceuticals position peaked at $5.44M in Q4 2023.
  • 1,309 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.